Newsroom | 4685 results

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including Metabolic dysfunction-Associated SteatoHepatitis (MASH) and rare metabolic disorders, today announces that five presentations in relation to the potential of Imeglimin, marketed under the brand name TWYMEEG® in Japan, will be made at the 85th Scientific Sessio...

ACTON, Mass.--(BUSINESS WIRE)--Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association Conference...

PORTLAND, Ore.--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment and diagnosis in maternal health, diabetes and autoimmune disease. “Throughout my career, I’ve seen firsthand the great need for more preventive healthcare solutions,” said Dr. Nagalla. “Too often doctors see patients after disease has already taken hold. My goal is to develop diagnostic tools that can assist in...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing AI-driven cardiometabolic care, today announced its selection by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. This national award recognizes top employers in the healthcare industry. The highly competitive selection process, conducted in partnership with Workforce Research Group, involved an extensive employee survey. Welldoc was named to the list alongside a select group of health tech...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States. During the conference, Dexcom will p...

AUSTIN, Texas--(BUSINESS WIRE)--A recent clinical trial from the founders of Beheld and a research team at the Dell Medical School has demonstrated that science-backed human connection can drive clinically relevant health improvements for health plan members. The study, published in JAMA Network Open, found that consistent, empathy-focused phone calls led to significant improvement in mental health and blood sugar control for adults with diabetes. This research highlights a cost-effective model...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the TrueLok™ Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented design for use in the TBT procedure to provide a limb preservation treatment option for addressing bony or soft tissue deformities or defects, such as diabetic ulcers. “I have b...

NEW YORK & ISTANBUL--(BUSINESS WIRE)--Semaglutide cuts kidney disease risk by 26% in T2D patients, confirms large real-world study by Columbia Data Analytics and partners....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--İş Private Equity, a subsidiary of Türkiye İşbank Group, has launched Enlila, a biotechnology venture, for the purpose of entering into a sponsored research agreement with the Hotamışlıgil Lab at Harvard T.H. Chan School of Public Health. Research led by Prof. Gökhan Hotamışlıgil had elucidated a fundamental mechanism underlying obesity and age-related diseases. Preclinical studies indicate that this mechanism has significant therapeutic potential, and the Hot...

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect Pancreatic Cancer Test....